Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 72, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 3 September 2026 - 12:53

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 72, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/keytruda

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters